Ó£»¨ÊÓƵ

Skip to main content

Table 3 Clinical characteristics of hypertensive patients followed at primary healthcare centers, Marrakech, 2021–2022

From: The silent struggle: assessing anxiety prevalence in Marrakech’s hypertensive population

Ìý

Total participants

n (%)

Self-reported anxiety n = 348

No self-reported anxiety n = 705

Comorbidity

ÌýÌýÌý

 Y±ð²õ

508 (48.2)

186 (53.5)

322 (45.7)

 N´Ç

545 (51.8)

162 (46.5)

383 (54.3)

Diabetes

ÌýÌýÌý

 Y±ð²õ

458 (43.5)

169 (48.6)

289 (41.0)

 N´Ç

595 (56.5)

179 (51.4)

416 (59.0)

Dyslipidemia

ÌýÌýÌý

 Y±ð²õ

56 (05.3)

22 (06.3)

34 (04.8)

 N´Ç

997 (94.7)

326 (93.7)

671 (95.2)

Duration of hypertension

ÌýÌýÌý

 More than five years

499 (47.4)

181 (52.0)

318 (45.1)

 Less than or equal to five years

554 (52.6)

167 (48.0)

387 (54.9)

Family history of hypertension

ÌýÌýÌý

 Y±ð²õ

601 (57.1)

248 (71.3)

353 (50.0)

 N´Ç

452 (42.9)

100 (28.7)

352 (50.0)

Controlled blood pressure

ÌýÌýÌý

 N´Ç

749 (71.1)

256 (73.6)

493 (69.9)

 Y±ð²õ

304 (28.9)

92 (26.4)

212 (30.1)

Autonomy

ÌýÌýÌý

 Y±ð²õ

79 (07.5)

37 (10.6)

42 (06.0)

 N´Ç

974 (92.5)

311 (89.4)

663 (94.0)

Reduced mobility

ÌýÌýÌý

 Y±ð²õ

126 (12.0)

64 (18.4)

62 (08.8)

 N´Ç

927 (88.0)

284 (81.6)

643 (91.2)

Pain and physical discomfort

ÌýÌýÌý

 Y±ð²õ

587 (55.8)

240 (69.0)

347 (49.2)

 N´Ç

466 (44.2)

108 (31.0)

358 (50.8)

Overweight or obesity

ÌýÌýÌý

 Y±ð²õ

843 (80.1)

296 (85.1)

547 (77.6)

 N´Ç

210 (19.9)

52 (14.9)

158 (22.4)